SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-060045
Filing Date
2012-08-24
Accepted
2012-08-24 16:15:34
Documents
5
Period of Report
2012-08-24
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-18984_18k.htm 8-K 37465
2 EX-3.1 a12-18984_1ex3d1.htm EX-3.1 35577
3 EX-99.1 a12-18984_1ex99d1.htm EX-99.1 14988
4 GRAPHIC g189841mmi001.jpg GRAPHIC 3409
5 GRAPHIC g189841mmi002.jpg GRAPHIC 1859
  Complete submission text file 0001104659-12-060045.txt   96972
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 121054821
SIC: 2834 Pharmaceutical Preparations